IL4R and colonic neoplasm: AP-1 (human atherosclerotic plaque-specific peptide-1)-conjugated liposomal conjugate specifically targeted at IL4Rα, showed an anti-cancer effect on IL4Rα-overexpressing colon cancer cells [36].